Patanjali CEO Acharya Balkrishna said all procedures were followed to manufacture Coronil.
This comes after MoS for the Union Ayush Ministry Shripad Naik said that Patanjali Ayurved should not have advertised its newly-launched ayurvedic drugs for COVID-19 before getting final approvals.
Balkrishna said that Patanjali didn’t advertise the medicine but tried to tell people about the results of clinical trial.
Watch the full video for more.
